Medline
MDLN
37.04
-0.80
-2.11%
Medline
US · MDLN
#667 by market cap
Listed 2025
37.04
-0.80
-2.11%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Analysts Conflicted on These NA Names: Venture Global, Inc. Class A (VG), ServiceTitan, Inc. Class A (TTAN) and Medline (MDLN)TipRanks · 2026/10/8
-
Rating change
Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $43Market Newswire · 2026/10/8
-
Rating change
A Quick Look at Today's Ratings for Medline(MDLN.US), With a Forecast Between $44 to $49Market Newswire · 2026/11/6
-
Rating change
Barclays Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $43Market Newswire · 2026/11/4
-
Rating change
Truist Financial Maintains Medline(MDLN.US) With Buy RatingMarket Newswire · 2026/9/22
-
Rating change
Bernstein Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $49Market Newswire · 2026/11/5
-
Rating change
Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $43Market Newswire · 2026/9/16
-
Rating change
William Blair Maintains Medline(MDLN.US) With Buy RatingMarket Newswire · 2026/9/23
-
Rating change
Mizuho Securities Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $45Market Newswire · 2026/10/22
-
Tigress Financial Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/11/14
-
Rating change
Citi Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $47Market Newswire · 2026/11/5
-
Rating change
BofA Securities Maintains Medline(MDLN.US) With Buy RatingMarket Newswire · 2026/11/10
-
Rating change
Baird Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $44Market Newswire · 2026/11/5
-
RBC Capital Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $46Market Newswire · 2026/11/11
-
Medline Expects Offering to Close Nov. 23 MDLNDow Jones · 2026/11/18
-
Rating change
Barclays Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $43Market Newswire · 2026/10/9
-
Barclays Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/11/20
-
Rating change
UBS Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $43Market Newswire · 2026/9/25
-
Rating change
Analysts Offer Insights on NA Companies: Ingram Micro Holding Corporation (INGM), WW International, Inc. (WW) and Medline (MDLN)TipRanks · 2026/9/16
-
J.P. Morgan Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/11/13
-
Rating change
Analysts Are Bullish on These NA Stocks: Medline (MDLN), Navan, Inc. Class A (NAVN)TipRanks · 2026/9/10
-
Rating change
RBC Capital Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $46Market Newswire · 2026/10/7
-
Rating change
Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $34.05Market Newswire · 2026/9/10
-
Rating change
Analysts Offer Insights on NA Companies: Veeva Systems (VEEV), Blue Owl Technology Finance Corp. (OTF) and Medline (MDLN)TipRanks · 2026/8/27
-
Rating change
Analysts Offer Insights on NA Companies: Alliance Laundry Holdings, Inc. (ALH) and Medline (MDLN)TipRanks · 2026/8/26
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Medline discussion 0 comments